News

A look at current strategies from the industry that address the limitations in clinical trials.

Click the title above to open the Applied Clinical Trials September 2018 issue in an interactive PDF format.

To support complex in-home clinical research and investigative sites, well-designed trials must produce the same high-quality data as traditional sites.

Alzheimer's Prevention Initiative's discusses a genetic counseling and disclosure model for its Generation Program.

Site models that meet patient needs at the site level.

Partnership focuses on integrating research into the care continuum.

Case study highlights a new patient-centric enrollment model that uses a data-driven approach to identify qualified patients first.

Reexamining traditional cycle-time reduction strategies is critical for sponsors, CROs, and sites.

The relationship between European patients and drug developers has gone through many twists and turns over the years-and is still seeking equilibrium.

Comprehensive market landscaping includes disparate data sets from primary and secondary sources and is a time-consuming process that requires domain expertise and commitment.

Michael Sydes outlines some strategies that CRA's can use to maintain good clinical practices.

As part of efforts to speed patient access to effective new therapies, FDA is rolling out policies designed to streamline drug development, particularly for new cancer therapies to treat life-threatening conditions.

Updated employee announcements, business news, awards, and recognition in the industry today.